Qiming Venture Partners' Duane Kuang, William Hu, and Alex Zhou Named to PEDaily's 2025 TOP100 Investors List
The awards have been held for ten consecutive editions, becoming a window into observing industry shifts, with the aim of selecting 100 outstanding investors who have delivered strong investment performance while also driving progress in China's venture capital landscape.
On the eve of the 19th China Fund Partners Conference, the 2025 PEDaily TOP100 Investors list, jointly launched by PEDaily — the venture and investment information platform under Zero2IPO — and Zero2IPO Research, was officially announced. Now in its tenth consecutive year, the ranking has become a window for observing industry shifts, aiming to identify 100 outstanding investors who have achieved strong investment performance while driving progress in China's venture capital landscape.
Duane Kuang, Founding Managing Partner of Qiming Venture Partners; William Hu, Managing Partner of Qiming Venture Partners; and Alex Zhou, Managing Partner of Qiming Venture Partners, were all selected.
Duane Kuang Founding Managing Partner, Qiming Venture Partners
William Hu Managing Partner, Qiming Venture Partners
Alex Zhou Managing Partner, Qiming Venture Partners
Named
2025 PEDaily TOP100 Investors
2025 PEDaily TOP100 Investors
PEDaily, Zero2IPO Research, and the PEDATA system compiled tens of thousands of investment records for candidates dating back to January 2023. The evaluation weighed five key factors: number of personal investments, personal investment amount, overall return performance, and the individual and institutional influence in the industry. The final list was drawn from a pool of over 1,000 candidates.
Source | PEDaily
Past Highlights
Qiming Honors | Qiming Venture Partners Ranks 5th on Zero2IPO's 2024 China Venture Capital Firms List, Among Five Major Awards Qiming Headlines | Qiming Venture Partners and Portfolio Companies Win Multiple Awards on ChinaVenture's 2024 Rankings, Including Top 5 China Best Venture Capital Firms Rising Stars | Four Qiming Venture Partners Portfolio Companies Named to World Artificial Intelligence Conference SAIL Award TOP30 List
Founded in 2006, Qiming Venture Partners currently manages 11 USD funds and 7 RMB funds, with total assets under management reaching $9.5 billion. Since its inception, the firm has focused on investing in excellent early- and growth-stage companies in the Technology and Consumer (T&C) and Healthcare sectors.
To date, Qiming Venture Partners has invested in over 580 high-growth innovative companies. More than 210 of these have gone public on the New York Stock Exchange, NASDAQ, Hong Kong Exchanges and Clearing Limited, Shanghai Stock Exchange, and Shenzhen Stock Exchange, or exited through mergers and acquisitions. Over 80 portfolio companies have become recognized unicorns or super-unicorns.
Many of Qiming Venture Partners' portfolio companies have grown into the most influential players in their respective fields, including Xiaomi (01810.HK), Meituan (03690.HK), Bilibili (NASDAQ:BILI, 09626.HK), Zhihu (NYSE:ZH, 02390.HK), Roborock (688169.SH), UBTECH (09880.HK), WeRide (NASDAQ:WRD), Insta360 (688775.SH), Gan & Lee Pharmaceuticals (603087.SH), Tigermed (300347.SZ, 03347.HK), Zai Lab (NASDAQ:ZLAB, 09688.HK), CanSino Biologics (688185.SH, 06185.HK), Schrödinger (NASDAQ:SDGR), MicroPort EP MedTech (688617.SH), Sanyou Medical (688085.SH), Amoy Diagnostics (300685.SZ), Berry Genomics (000710.SZ), SinoCellTech (688520.SH), Yuanxin Technology, Insilico Medicine, MediLink Therapeutics, LaNova Medicines, Zhipu AI, StepFun, and Biren Technology.